Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Clinical trial NCT07508306 · RECRUITING

Trial details

NCT number: NCT07508306
Sponsor: Faculty of Medicine of Tunis
Status: RECRUITING
Study type: OBSERVATIONAL

Sentinel Lymph Node Biopsy (SLNB)Early Stage Ovarian Tumors

Start date: 2026-04-15
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.